Donald Hsu

1.5k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Donald Hsu is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Donald Hsu has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Clinical Biochemistry and 4 papers in Epidemiology. Recurrent topics in Donald Hsu's work include Antimicrobial Resistance in Staphylococcus (9 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (4 papers). Donald Hsu is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (4 papers). Donald Hsu collaborates with scholars based in United States, Norway and Canada. Donald Hsu's co-authors include Annie Wong‐Beringer, Levita Hidayat, Ryan Quist, Kimberly Shriner, Mark Bounthavong, Janet Hindler, Åsa Karlsson, Anandi V. Law, Mark P. Okamoto and Rekha Murthy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Donald Hsu

14 papers receiving 1.2k citations

Hit Papers

High-Dose Vancomycin Therapy for Methicillin-Resistant St... 2006 2026 2012 2019 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections
    2006 691 citations Levita Hidayat, Donald Hsu et al. Archives of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald Hsu United States 11 868 579 352 324 194 16 1.2k
Levita Hidayat United States 11 737 0.8× 575 1.0× 302 0.9× 245 0.8× 190 1.0× 18 1.2k
Jeffrey Graves United States 8 860 1.0× 685 1.2× 467 1.3× 363 1.1× 166 0.9× 9 1.3k
Nadia Z. Haque United States 16 983 1.1× 597 1.0× 215 0.6× 297 0.9× 392 2.0× 32 1.3k
Pamela A. Moise-Broder United States 4 1.3k 1.5× 853 1.5× 570 1.6× 432 1.3× 254 1.3× 5 1.6k
Kimberly Shriner United States 9 705 0.8× 413 0.7× 255 0.7× 280 0.9× 132 0.7× 16 1.1k
Carisa De Anda United States 14 832 1.0× 358 0.6× 287 0.8× 261 0.8× 251 1.3× 38 1.1k
H. David Friedland United States 19 958 1.1× 440 0.8× 594 1.7× 529 1.6× 233 1.2× 39 1.5k
Donald H. Batts United States 17 1.3k 1.4× 539 0.9× 351 1.0× 500 1.5× 164 0.8× 22 1.7k
William O’Riordan United States 20 1.1k 1.3× 627 1.1× 431 1.2× 493 1.5× 455 2.3× 38 1.8k
Kenneth J. Tack United States 24 684 0.8× 358 0.6× 490 1.4× 622 1.9× 294 1.5× 45 1.6k

Countries citing papers authored by Donald Hsu

Since Specialization
Citations

This map shows the geographic impact of Donald Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Hsu more than expected).

Fields of papers citing papers by Donald Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Hsu. The network helps show where Donald Hsu may publish in the future.

Co-authorship network of co-authors of Donald Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Hsu. A scholar is included among the top collaborators of Donald Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Hsu. Donald Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hsu, Donald, et al.. (2022). A Longitudinal Integrative Course Series to Prepare Students for Advanced Pharmacy Practice Experiences. SHILAP Revista de lepidopterología. 13(2). 12–12. 1 indexed citations
2.
Bounthavong, Mark, et al.. (2013). Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination. Infection and Drug Resistance. 6. 215–215. 37 indexed citations
3.
Bounthavong, Mark & Donald Hsu. (2012). Cost–effectiveness of linezolid in methicillin-resistantStaphylococcus aureusskin and skin structure infections. Expert Review of Pharmacoeconomics & Outcomes Research. 12(6). 683–698. 6 indexed citations
4.
5.
6.
Hsu, Donald, et al.. (2011). Assessment of patient communication skills during OSCE: Examining effectiveness of a training program in minimizing inter-grader variability. Patient Education and Counseling. 83(3). 472–477. 34 indexed citations
7.
Hsu, Donald, M. Hong Nguyen, Long H. Nguyen, Anandi V. Law, & Annie Wong‐Beringer. (2010). A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. Journal of Antimicrobial Chemotherapy. 65(8). 1765–1770. 48 indexed citations
8.
9.
Bounthavong, Mark & Donald Hsu. (2009). Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Current Medical Research and Opinion. 26(2). 407–421. 42 indexed citations
10.
11.
Nguyen, Long H., Donald Hsu, Vadivel Ganapathy, Kimberly Shriner, & Annie Wong‐Beringer. (2008). Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome. Journal of Antimicrobial Chemotherapy. 61(3). 714–720. 13 indexed citations
12.
Hsu, Donald, Levita Hidayat, Ryan Quist, et al.. (2008). Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections. International Journal of Antimicrobial Agents. 32(5). 378–385. 144 indexed citations
13.
Hidayat, Levita, Donald Hsu, Ryan Quist, Kimberly Shriner, & Annie Wong‐Beringer. (2006). High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections. Archives of Internal Medicine. 166(19). 2138–2138. 691 indexed citations breakdown →
14.
Hsu, Donald, Mark P. Okamoto, Rekha Murthy, & Annie Wong‐Beringer. (2005). Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes. Journal of Antimicrobial Chemotherapy. 55(4). 535–541. 69 indexed citations
15.
Beringer, Paul M., Nils Hoem, Stan G. Louie, et al.. (2005). Absolute Bioavailability and Intracellular Pharmacokinetics of Azithromycin in Patients with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. 49(12). 5013–5017. 46 indexed citations
16.
Farooq, Amjad, et al.. (1995). Rheological properties of alumina‐polyacrylate gel dispersions. Journal of the American Oil Chemists Society. 72(7). 843–852. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Levita Hidayat Breakdown of academic impact, for papers by Jeffrey Graves Breakdown of academic impact, for papers by Nadia Z. Haque Breakdown of academic impact, for papers by Pamela A. Moise-Broder Breakdown of academic impact, for papers by Kimberly Shriner Breakdown of academic impact, for papers by Carisa De Anda Breakdown of academic impact, for papers by H. David Friedland Breakdown of academic impact, for papers by Donald H. Batts Breakdown of academic impact, for papers by William O’Riordan Breakdown of academic impact, for papers by Kenneth J. Tack
Rankless by CCL
2026